Institutions / Gilead Sciences, Inc.

Gilead Sciences, Inc.

CIK 882095 · Institutionalso an insider · as of Dec 31, 2025gilead.com ↗
Portfolio value
$1.94B
Positions
6
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Arcus Biosciences, Inc.—$748.85M31,424,76038.7%
Galapagos NV—$550.62M16,707,47728.4%
Arcellx, Inc.—$438.20M6,720,80322.6%
Assembly Biosciences, Inc.ASMBCommon Stock$153.23M4,505,3917.9%
Kyverna Therapeutics, Inc.KYTXCommon Stock$38.79M4,126,1192.0%
Xilio Therapeutics Inc—$5.83M9,105,4510.3%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.

Insider transactions

Also files Forms 3 / 4 / 5
DateActionCompanyValueShares ΔPosition afterImpact
Feb 13, 2026BuyXLO
Xilio Therapeutics, Inc.
Prefunded Warrants (right to buy)
—+3.7M
+10.20%
40,384,266
698.39% of shares
low